Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;35(11):1914-1915.
doi: 10.1002/mds.28325. Epub 2020 Oct 15.

Coronavirus Disease 2019 Case Fatality and Parkinson's Disease

Qiang Zhang  1 , Jordan L Schultz  1   2 , Georgina M Aldridge  1 , Jacob E Simmering  3 , Nandakumar S Narayanan  1
Affiliations

Coronavirus Disease 2019 Case Fatality and Parkinson's Disease

Qiang Zhang et al. Mov Disord. 2020 Nov.
No abstract available

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Patients with coronavirus disease 2019 (COVID‐19) with Parkinson's disease (PD) have an increased case fatality rate. (A) Patients with COVID‐19 with PD (n = 694) have an increased case fatality rate compared with those without PD (n = 78,355; odds ratio [OR], 1.27; 95% confidence interval, 1.04–1.53; P = 0.016). Logistic regression was performed with age, sex, and race included as covariates. Data from 79,049 patients with COVID‐19 in the TriNetX COVID‐19 research network. Each dot represents the model fit of each year for patients with PD and those without PD. (B) The COVID‐19 case fatality rate was higher across age groups >50 years.
See this image and copyright information in PMC

References

    1. Antonini A, Leta V, Teo J, Chaudhuri KR. Outcome of Parkinson's disease patients affected by COVID‐19. Mov Disord 2020;35:905–908. - PMC - PubMed
    1. Cilia R, Bonvegna S, Straccia G, et al. Effects of COVID‐19 on Parkinson's disease clinical features: a community‐based case‐control study. Mov Disord 2020;35:1287–1292. - PMC - PubMed
    1. Fasano A, Cereda E, Barichella M, et al. COVID‐19 in Parkinson's disease patients living in Lombardy, Italy. Mov Disord 2020;35:1089–1093. - PMC - PubMed
    1. Fasano A, Elia AE, Dallocchio C, et al. Predictors of COVID‐19 outcome in Parkinson's disease. Parkinsonism Relat Disord 2020;78:134–137. - PMC - PubMed
    1. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention . The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID‐19) in China. Zhonghua Liu, Xing Bing, Xue Za Zhi 2020;41:145–151. - PubMed

Publication types